Zai Lab Executive and Leadership Team

Kari Lee, the Deputy Chief Financial Officer at Zai Lab, directs financial operations and strategic fiscal planning. Overseeing budgetary controls and financial reporting, Lee ensures adherence to regulatory compliance and supports the company's growth initiatives in oncology and autoimmune disease research. This leadership position involves close collaboration with other finance executives to optimize resource allocation and manage financial risk effectively. By driving financial efficiency, Kari Lee contributes directly to Zai Lab's mission of developing innovative therapies. The role demands meticulous attention to detail and a deep understanding of pharmaceutical financial landscapes. Lee's oversight extends to managing financial models that underpin drug discovery and commercialization efforts, ensuring sustainable operations.

Diana Liu, the Deputy Chief Financial Officer at Zai Lab, manages critical aspects of the company's financial architecture. Liu's responsibilities encompass financial analysis, forecasting, and the implementation of robust financial systems to support Zai Lab's bio-pharmaceutical endeavors. This role is pivotal in ensuring the financial health of the organization as it navigates the complexities of drug discovery and development in oncology and autoimmune diseases. Diana Liu works in tandem with other finance leaders to drive fiscal discipline and strategic investment decisions. The position requires a comprehensive grasp of financial markets and the unique economic drivers within the life sciences sector. Liu's financial acumen directly supports the company's expansion and operational effectiveness.

Xiaoxi Wang, the Deputy Chief Financial Officer at Zai Lab, spearheads key financial strategies and operational efficiencies. Wang's purview includes managing financial reporting, internal controls, and capital management to bolster Zai Lab's research and development pipeline in oncology and autoimmune diseases. This executive function is crucial for maintaining financial integrity and supporting the company's long-term strategic objectives. Xiaoxi Wang collaborates with executive leadership to ensure financial resources are optimally deployed for maximum impact. The role necessitates a sharp analytical mind and expertise in financial compliance within the biopharmaceutical industry. Wang's contributions are vital for sustaining Zai Lab's innovative drug discovery efforts and market presence.

William Liang, the Chief Commercial Officer & President, Greater (China) at Zai Lab, drives market access and commercialization strategies. Liang oversees the sales, marketing, and business development functions, focusing on expanding Zai Lab's presence in key therapeutic areas like oncology and autoimmune diseases within the Greater China region. This leadership role is instrumental in translating scientific innovation into accessible patient treatments. William Liang works closely with R&D and medical affairs to ensure commercial strategies align with clinical development milestones and market needs. The position requires extensive knowledge of the pharmaceutical market dynamics in China and a proven track record in commercial leadership. Liang's strategic direction fuels Zai Lab's growth and patient impact.

Harald Reinhart, the Chief Medical Officer at Zai Lab, directs the company's clinical development strategy and medical affairs. Reinhart oversees the design and execution of clinical trials for novel therapies targeting oncology and autoimmune diseases, ensuring scientific rigor and regulatory compliance. This critical role involves leading medical teams, interpreting clinical data, and fostering relationships with key opinion leaders and regulatory bodies. Harald Reinhart's expertise guides the progression of Zai Lab's drug candidates from preclinical research through to market approval. The position demands a profound understanding of disease biology, clinical pharmacology, and global healthcare landscapes. Reinhart's leadership is fundamental to advancing Zai Lab's mission of bringing life-changing medicines to patients.